Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Schmitt J, Comoy P, Bottard J, Meingan JP, Le Meur J, Briot M (1966) Chim Ther:71–77
Schmitt J, Comoy P, Bottard J, Meingan JP, Le Meur J, Briot M (1966) Chim Ther:71–77
Lanz R, Peskar BA, Brune K (1986) Agents Actions 19 (Suppl): 125–135
Florian P,Kuncicky J; CS 226947; CA (1987) 106: 18544
Banci F, Bulgini MJ, Tubaro E (1971) Arzneim Forsch 21: 1665–1667
Ebel S (1977) Handbuch der Arzneimittelanalytik, Verlag Chemie, Weinheim, New York, S. 95–99
Gübitz G, Wintersteiger R (1976) Sci Pharm 44: 23–28
Banci F, Del Grande P, Monai A (1970) Arzneim Forsch 20: 1030–1032
Maurer H, Pfleger K (1983) Fresenius’Z Anal Chem 314: 586–594
Marciniec B (1984) Acta Pol Pharm 41: 185–193
Hoogewijs G, Matterne J, Massart DL (1980) Anal Lett 13 (B8): 691–704
Jarzebinski J, Gryz K (1988) Acta Pol Pharm 45: 422–427
Marciniec B (1985) Pharmazie 40: 30–33
Sacks W (1980) S Afr Med J 58: 444–446
Brune K, Alpermann H (1983) Agents Actions 13: 360–363
Lanz R, Peskar BA, Brune K (1986) Agents Actions 19 (Suppl): 125–135
Ebel S (1977) Handbuch der Arzneimittelanalytik, Verlag Chemie, Weinheim, New York, S. 97
Dibbern HW (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf, Spektr. Nr. 132
Teetz V, Geiger R, Henning R, Urbach H (1984) Arzneim Forsch 34: 1399–1401
Teetz V, Geiger R, Urbach H, Becker R, Schoelkens B (1983) EP 79022 A2, zit. nach CA 100: 5 2012h
Teetz V, Geiger R, Urbach H, Becker R, Schoelkens B (1983) DE 3226768 Al, zit. nach CA 99:158854k
Geiger R, Teetz V, Urbach H, Henning R (1984) DE 3303139 Al, zit. nach CA 102: 25038f
Urbach H, Henning R, Wissmann H, Teetz V (1985) EP 135181A2, zit. nach CA 103:160858j
Gold EH, Neustadt BR, Smith EM (1986) US 4587258 Al, zit. nach CA 105:134346n
Gold EH, Neustadt BR, Smith EM (1986) WO 8600896 Al, zit. nach CA 105:226337p
Tremul Lozano J (1986) ES 549789 Al, zit. nach CA 106: 85063c
Verde Casanova MJ (1986) ES 549251 Al, zit. nach CA 107: 59483r
Oudenes J, Schleicher RH (1989) ES 2004804 A6, zit. nach C A 114:207829V
Rueger W, Urbach H, Becker R, Hock F (1989) EP 326974 Al, zit. nach CA 112: 56694c
Lt. Mitt, der Fa. Astra Chemicals
Aboul-Enein HY, Thiffault C (1991) Anal Lett 24: 2217–2224
Aboul-Enein HY, Bakr SA (1992) Drug Dev Ind Pharm 18:1013–1022, zit. nach CA 117: 56105q
Gustafsson S, Eriksson BM, Nilsson I (1990) J Chromatogr 506: 75–83
Burnier M, Waeber B, Nussberger J, Brunner HR (1990) Drugs 39 (Suppl I): 32–38
McAreavey D, Robertson JIS (1990) Drugs 40: 326–345
Todd PA, Benfield P (1990) Drugs 39: 110–135
Robertson IS (Hrsg.) (1987) Am J Cardiol 59: 1D–177D
Schilling H, Scheler F (1988) Z Kardiol 77 (Supp 3):47–544.
Dzau VJ (1990) Drugs 39 (Suppl 2): 11–16
Eckert HG, Badian MJ, Ganzt D, Kellner HM, Volz M (1984) Arzneim Forsch 34: 1435–14471.
Price BJ, Clitherow JW, Bradshaw JW (1977) DOS 2734070, zit. nach CA (1978) 88: 190580b
Cholerton TJ, Hunt JH, Klinkert G, Martin-Smith M (1984) J Chem Soc Perkin Trans II: 1761–1766
Hohnjec M, Kuftinec J, Malnar M, Skreblin M, Kajfez F, Nagl A, Blazevic N (1986). In: Ana, Bd.15, S. 53–561
Daly M J, Humphrey JM, Stables R (1981) Br J Pharmacol 72: 49–54
Stables R, Daly MJ (1980) Agents Actions 10: 191–192
Sewing KF, Hannemann H (1986) Pharmacology 33: 274–278
Goelzer SL, Farin-Rusch C, Coursin DB (1988) Crit Care Med 16: 8–10
DalNegro RW, Turco P, Zoccatelli O (1984) Int J Clin Pharmacol Res 4: 481–482
Lanzon-Miller S, Pounder RE, Hamilton MR, Ball S, Chronos NAF (1987) Aliment Pharmacol Ther 1: 239–251
McFayden ML, Folb PI, Miller R, Keeton GR, Marks IN (1983) Eur J Clin Pharmacol 25: 347–351
McFayden ML, Folf PI, Marks IN, Wright JP, Lucke W (1981) Scand J Gastroenterol 16 (Suppl.69): 109
Chau NP, Zech PY, Pozet N, Hadj-Aissa A (1982) Clin Pharmacol Ther 13: 770–774
Konturek SJ (1982) M Sinai J Med 49:370–382
Garg DC, Weidler DJ, Baltodano N, Eshelman FN (1981) Clin Pharmacol Ther 29: 248
Kagevi I, Wählby L (1985) Lancet I: 164–16513.
Riley AJ, Crowley P, Harrison C (1982) Transfer of ranitidine to biological fluids: milk and semen. In: Misiewicz JJ, Wormsley KG (Hrsg.) The clinical use of ranitidine, Medicine Publishing Foundation Series 5, Medicine Publishing Foundation, Oxford, S. 77–86
Garg DC, Weidler DJ, Eshelman FN (1983) Clin Pharmacol Ther 33: 445–452
Cary PF, Martin LE, Owen P (1981) Biochem Soc Trans 1: 112
Garg DC, Baltodano N, Jallad NS, Perez G, Oster JR (1986) J Clin Pharmacokin 26: 286–291
Grant SM, Langtry HD, Brodgen RN (1989) Drugs 37: 801–870
Epstein CM, Klopper J (1985) Headache 25: 392–393
MacDermott AJ, Insole J, Kaufman B (1987) Br Med J 294: 1616
Price W, Coli K, Brandstetter RD, Gotz VP (1985) Eur J Clin Pharmacol 29: 375–376
Souza Lima MA (1984) Ann Int Med 101: 207–208
Gafter U, Komlos L, Weinstein T, Zevin D, Levi J (1987) Ann Int Med 106: 447
Brenner LO (1986) Ann Int Med 104: 896
Tosi S, Cagnoli M (1982) Lancet 2: 160
Johnson WS, Miller DR (1988) Ann Int Med 108: 493
Allegri G, Pellegrini K, Dobrilla G (1988) Agents Actions 24: 237–242
Haboubi N, Asquith P (1988) Br Med J 296: 897
Vial T, Goubier C, Bergeret A, Cabrera F, Evreux GC, Decotes J (1991) Drug Safety 6: 94–117
Poynter D, Pick CR, Harcourt RA, Sutherland MF, Spurling NW (1982) Evaluation of ranitidine safety. In: Misiewicz JJ, Wormsley KG (Hrsg.) The clinical use of ranitidine, Medicine Publishing Foundation Series 5, Medicine Publishing Foundation, Oxford, S. 48–55
Havu N, Mattsson H, Ekman K, Carlsson E (1990) Digestion 45: 189–195
Hohnjec M, Kuftinec J, Malnar M, Skreblin M, Kajfez F, Nagl A, Blacevic N (1986) Ana 15, S. 533–561
Moffat AC (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London, S. 956
Dibbern HW (Hrsg.) (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf
Cholerton TJ, Hunt JH, Klinkert G, Martin-Smith M (1984) J Chem Soc Perkin Trans 11: 1761–1984
Fisher MJ, Myers CD, Joglar J, Chen SH, Danishefsky SJ (1991) J Org Chem 56: 5826–5834
Chen SH, Horvath RF, Joglar J, Fisher MJ, Danishefsky SJ (1991) J Org Chem 56: 5834–5845
Nicolaou KC, Chakraborty TK, Piscopio AD, Minova N, Bertinato P (1993) J Am Chem Soc 115: 4419–4420
Meyer SD, Miwa T, Nakatsuka M, Schreiber SL (1992) J Org Chem 57: 5058–5060
Romo D, Johnson DD, Plamondon L, Miwa M, Schreiber SL (1992) J Org Chem 57: 5060–5063
Hale MR, Hoveyda AH (1992) Org Chem 57: 1643–1645
Pattenden G, Tankard M, Cherry PC (1993) Tetrahedron Lett:2677–2680
Piscopio AD, Minova N, Chakraborty TK, Koide K, Bertinato P, Nicolaou KC (1993) J Chem Soc Chem Commun:617–618
Nicolaou KC, Bertinato P, Piscopio AD, Chakraborty TK, Minova N (1993) J Chem Soc Chem Commun 619–622
McAlpine JB, Swanson SJ, Jackson M, Whittern DN (1991) J Antibiot 44: 688–690
Segha ISN, Blazekovic TM, Vezina C (1975) US Pat 3, 929, 992
Vezina C, Kudelski A, Seghal SN (1975) J Antibiot 28: 721–726
Seghal SN, Baker H, Vezina C (1975) J Antibiot 28: 727–732
Findlay JA, Radics L (1980) Can J Chem 58: 579–590
Findlay JA, Liu JS, Burnell DJ, Nakashima TT (1982) Can J Chem 60: 2046–2047
Kessler H, Haessner R, Schuler W (1993) Helv Chim Acta 76: 117–130
Yatscoff RW, Faraci C, Bolinbroke P (1992) Ther Drug Monit 14: 138–141
Napoli KL, Kahan BD (1991) Clin Chem 37: 294–295
Morris RE (1991) Immunol Today 12: 137–140
Sigal NH, Dumont FJ (1992) Ann Rev Immunol 10: 519–560
Bierer BE, Mattila PS, Standaert RF, Herzenberg LA, Burakoff SJ, Crabtree G, Schreiber SL (1990) Proc Nat Acad Sci 87: 9231–9235
Zheng B (1991) Transplant Proc 23: 851–855
Wu J, Palladino MA, Figari IS, Morris RE (1991) Transplant Proc 23: 238–240
Hanke TH, Nichols LN, Coon ME (1992) Lymphokine Cytokine Res 11: 221–231
Wicker LS, Boltz RC, Matt V, Nichols EA, Peterson LB, Sigal NH (1990) Eur J Immunol 20: 2277–2283
Dumont FJ, Melino MR, Staruch MJ, Koprak SL, Fischer PA, Sigal NH (1990) J Immunol 144: 1418–1424
Hatfield SM, Mynderse JS, Roehm NW (1992) J Pharmacol Exptl Ther 261: 970–976
Douros J, Suffness M (1981) Cancer Treatm Rev 8: 63–87
Eng CP, Sehgal SN, Vezina C (1984) J Antibiot 37; 1231–1237
Arcedi RJ, Stieglitz K, Bierer BE (1992) Blood 80: 1528–1536
Warner LM, Adams LM, Sehgal SN (1994) Arthritis Rheum 37: 289–297
Baeder WL, Sredy J, Sehgal SN, Chang JY, Adams LM (1992) Clin Exp Immunol 89: 174–178
Fryer J, Yatscoff RW, Pascoe EA, Thliveris J (1993) Transplantation 55: 340–345
Yatscoff R, Le Gatt D, Keenan R, Chackowsky P (1993) Transplantation 56; 1202–1206
Supko JG, Malspeis L (1994) Cancer Chemother Pharmacol 33: 325–330
Honcharik N, Foyer J, Yatsoff R (1992) Therap Drug Monit 14: 475–178
Sattler M, Guengerich FP, Yun CH, Christians U, Sewing KF (1992) Drug Metab Dispos 20: 753–761
Calne RY, Lim S, Samaan A, Collier SJ, Pollard SG, White DJG (1989) Lancet 2: 227
Morris RE, MeiserBM (1989) Med Sci Res 17: 609–610
Kahan BD, Gibbons S, Tejpal N, Stepkowski SM, Chou TC (1991) Transplantation 51: 232–239
Sehgal SN, Molnar-Kimber K, Ocain TD, Weichman BM (1994) Med Res Rev 14: 1–22
Carlson RP, Hartman D, Tomchek LA, Walter TL, Lugay R, Calhoun W, Sehgal SN, Chang JY (1993) J Pharmacol Exptl Ther 266: 1125–1136
Yatscoff RW, Fryer J, Thliveris JA (1993) Clin Biochem 26: 409–414
Dumont FJ, Staruch MJ, Koprak SL, Siekierka JJ, Liu CS, Harrison R, Sewell T, Kindt VM, Beattie TR, Wyvratt M (1992) J Exp Med 176: 751–760
Heinemann H (1934) Chem Ber 67; 15
Siddiqui S, Siddiqui RH (1931) J Indian Chem Soc 8: 667
van Tamelen EE, Placeway C (1961) J Am Chem Soc 83: 2594
Rose J (1955) Anal Chem 27: 469
Dibbern HW (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf
Mitteilungen der Fa. Rhone Poulenc-Rorer
Mar 29, S. 1517
Demichel P, Gomond P, Roquebert J (1982) Br J Pharmacol 77: 449–454
Demichel P, Roquebert J (1984) Br J Pharmacol 83: 505–510
Marzo A, Ghirardi P, Alessio R, Villa A (1977) Arzneim Forsch 27: 2343–2344
Borzeix MG, Cahn J (1987) Arzneim Forsch 37: 491–494
Mitteilungen der Fa. Rhône Poulenc-Rorer
Stoll A, Hofmann A (1953) Helv Chim Acta 36: 1143–1147
Petkovic, Miodrag (1970) Arh Farm 20:173–175, zit. nach CA 73 (24):1213461r
Robinson J (1977) EDRO SARAP Res Tech Rep 2:23–61, zit nach CA 88 (20):141759h
Bundesverband der pharmazeutischen Industrie (Hrsg.) (1991) Rote Liste, Editio Cantor, Aulendorf
Mar 29, S. 1657–1658
Kay AB (Hrsg.) (1984) Asthma — Physiology, immunpharmacology and treatment, Academic Press, Oxford
Habersang S, Leuschner F, Stroman F, Domenico A, von Schlichtegroll A (1977) Arzneim Forsch 27: 22–34
Laggner A, Kaik G, Kaik B (1984) Krankenhausarzt 59: 1082–1102
Leonhard KH, Cegla UH (1990) Therapiewoche 30: 7998–8001
Bateman JRM, Clarke SW, Pines A (1979) Clin Trials J 16: 37–40
Weiss T, Dorow P, Felix R (1983) Therapiewoche 33: 4022–4028
Hesse H, Kasparek R, Mizera W, Unterholzner Ch, Konietzko N (1981) Arzneim Forsch 31: 716–718
Di Mezza F, Giordano l, Ariello B, Scognamiglio M, Ruta A, Paone G, Marmo E (1981) Eur Rev Med Pharmacol Sci 3 (Suppl): 49–53
Hageman RJJ, de Zeeuw RA, Greving JE, Krann JJ, Koeter GH (1988) Biopharm Drug Dispos 9: 301–314
Mandi A, Wilde W, Galgoczy G, Aurich R, Galambos E (1977) Arzneim Forsch 27 (Suppl): 64–66
Niebch G, Klingler KH, Eikelmann G, Kucharczyk N (1978) Arzneim Forsch 28: 765–767
Heller A (1979) Spezifische Infusionsbehandlungbeim Status asthmaticus — Eine Toleranzstudie. In: Schmidt OP (Hrsg.) Obstruktive Atemwegserkrankungen, Verlag G Witzstrock, Baden-Baden, S. 30–33
Hussein A, von der Hardt H, Müller W, Schell SM (1986) Monatsschr Kinderheilkd 134: 192–196
Jansen W, Thoma R, Küpper HJ, Cipura W, Wichmann HE, Osterspey A, Behrenbeck DW, Tauchert M (1982) Intensivmedizin 19: 245–252
Nikolaus HJ, Wettengel R (1990) MUnch Med Wochenschr 132: 193–194
Schmutzler W, Kortemeier A, Riesener KP (1984) Pharmakotherapie 7: 1–8
Schultze-Werninghaus G, Bergmann EM (1986) Additive Wirkung von Reproterol und Dinatriumcromoglykat (DNCG) bei protektiver Inhalation vor allergeninduzierter Bronchialobstruktion. In: Nolte D, Kummer F, Dorow P (Hrsg.) Asthma bronchiale, Urban & Schwarzenberg, München Wien Baltimore, S. 242–250
Debelic M (1987) Atemw Lungenkrkh 13: 46–51
Klohs MW, Draper MD, Keller F (1955) J Am Chem Soc 77: 2241
Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London, S. 957
Hag, Bd.6, S.47
Woodward RB, Bader FE, Bickel H, Frey AJ, Kierstead RW (1956) J Am Chem Soc 78: 2023–2025
Woodward RB, Bader FE, Bickel H, Frey AJ, Kierstead RW (1958) Tetrahedron 2: 1–573
Pearlman BA (1979) J Am Chem Soc 101: 6404–6408
Wender PA, Schaus JM, White AW (1980) J Am Chem Soc 102: 6157–6159
Dorfman L, Furlenmeier A, Huebner CF, Lucas R, MacPhillamy HB, Mueller JM, Schlittler E, Schwyzer R, St Andre AF (1954) Helv Chim Acta 37: 59–75
Moffat AC (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London, S. 908
Suckow RF, Cooper AB, Asnis GM (1983) J Liq Chromatogr 6: 1111–1122
Near JA, Mahler JA (1983) FEBS Lett 158: 31–35
Manara L, Menninni T, Carminati P (1972) Eur J Pharmacol 17: 183–185
Giachetti A, Shore PA (1978) Life Sci 23: 89–92
Euler US, von Lishajko F (1963) Int J Neuropharmacol 2: 127–134
Deupree JD, Weaver JA (1984) J Biol Chem 259:10. 907–10. 912
Duval N, Hicks PE, Langer SZ (1986) Eur J Pharmacol 122: 93–101
Caughney B, Kirschner N (1986) J Neurochem 49: 563–573
Langer SZ, Punto JE (1976) J Pharmacol Exp Ther 196: 697–713
Kopin IJ, Gordon EK (1962) J Pharmacol Exp Ther 138: 351–359
Kopin IJ, Gordon EK (1963) J Pharmacol Exp Ther 140: 207–216
Shaskan EG, Snyder SH (1979) J Pharmacol Exp Ther 174: 404–418
Channick BJ, Kessler WB, Marks AD, Adlin EV (1981) Clin Ther 4: 175–183
Applegate WB, Carper ER, Kahn SE, Westbrook L, Linton M, Baker MG, Runyan JW jr (1985) J Am Geriat Soc 33: 109–115
Luxenberg J, Feigenbaum LZ (1983) J Am Geriat Soc 31: 556–559
Maass AR, Jenkins B, Shen Y, Tannenbaum P (1969) Clin Pharmacol Ther 10: 366–371
Mar 29, S. 498–500
Veterans Administration Cooperative Study Group on Hypertensive Agents (1970) J Am Med Assoc 213: 1143–1152
Veterans Administration Cooperative Study Group on Hypertensive Agents (1978) Ann NY Acad Sci 304: 267–292
Smirk FH, Doyle AE (1954) Lancet 1: 1096–1097
Klein F (1968) Hypotensive drugs. In: Meyer L, Herxheimer A (Hrsg.) Side effects of drugs, Excerpta Medica, Amsterdam, S. 202–211
Haverback BJ, Stevenson TD, Sjoerdsma A, Terry LL (1955) Am J Med Sci 230: 601–604
Stevenson JG, Umstead GS (1984) Clin Pharm 18: 113–121
Muradian RE (1986) Vopr Onkol 32: 76–81
Clarke EGC (1986) Isolation and Identification of Drugs, 2.Aufl., The Pharmaceutical Press, London, S. 959
Raghavan NV (1979) J Chromatogr 168: 523–525
Yeung D, Nacht S, Gans EH (1981) J Chromatogr 224: 1706–1707
Wachowiak R, Connors KA (1979) Anal Chem 51: 27–30
Roth HJ, Eger K, Troschutz R (1990) Arzneistoffanalyse, 3. Aufl., G.Thieme Verlag, Stuttgart, S. 61–64
Clayton GD, Clayton FE (1981) Bd. II A, Wiley Interscience, New York, S. 2586–2589
Yeung D, Kantor S, Nacht S (1983) Int J Dermatol 22: 321–324
Andersen KE, Maibach HI (1980) Clin Toxicol 16: 415–165
Keil H (1962) Arch Dermatol 86: 212–216
Caron GA, Calnan CD (1962) Trans John Hopkins Dermatol Soc 48: 149–156
Cunningham AA (1956) Arch Dis Child 31: 173–176
Wüthrich B, Zabrodsky S, Stork H (1970) Pharm Acta Helv 45: 453–460
Lüpke NP, Preusser P (1979) Aerztl Kosmetol 9: 341–346
Liu RS, Asato AE (1984) Tetrahedron 40: 1931–1969
Olson GL, Cheung HC (1976) J Org Chem 41: 3287
Moffat AC (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London
Bäßler KH, Grühn E, Loew D, Pietrzik K (1992) Vitamin Lexikon, Gustav Fischer Verlag, Stuttgart Jena
Friedrich W (Hrsg.) (1987) Handbuch der Vitamine, Urban und Schwarzenberg, Wien Baltimore
Liu RS, Asato AE (1984) Tetrahedron 40: 1931–1969
Olson GL, CheungHC (1976) J Org Chem 41: 3287
Harbison GS, Mulder PPJ, GriffinRG (1985) J Am Chem Soc 107 (17): 4809–4816
Moffat AC (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London
Moffat AC (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London
Karlson P (1977) Kurzes Lehrbuch der Biochemie, Georg Thieme Verlag, Stuttgart
Dibbern HW (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf
Bässler KH, Grühn E, Loew D, Pietrzik K (1992) Vitamin-Lexikon, Gustav Fischer Verlag, Stuttgart Jena
Monographie Riboflavin, BAz Nr. 46 vom 08. 03. 1988
Mar 30, S. 1054
Mar 30, S. 196
Mar29, S. 1610
Celmer WD, Sciavolino FC, Routien JB, Cullen WP (1975) DE 2500898, zit. nach CA (1975) 83: 191340g
Traxler P, Kump W, Mueller K, Tosch W (1990) J Med Chem 33: 552–560
Archifar Laboratori Chimico Farmacologici SpA (1980) AT 358171, zit. nach CA (1980) 94:103447w
Marsili L, Rosetti V, Pasqualucci C (1979) DE2825445, zit. nach CA (1979) 93: 239484
Cocchiara G, Strolin Benedetti M, Vicario GP, Ballabio M, Gioia B, Vioglio S, Vigevani A (1989) Xenobiotica 19: 769–780
Skinner MH, Hsieh M, Torseth J, Pauloin D, Bhatia G, Harkonnen S, Mergian TC, Blaschke TF (1989) Antimicrob Agents Chemother 33: 1237–1241
Lewis RC, Hatfield NZ, Narang PK (1991) Pharm Res 8: 1434–1440
Uges en Medewerkers DRA (1989) Ziekenhuisfarmacie 5:33–36, zit. nach CA (1989) 111:126353w
Della Bruna C, Schiopacassi G, Ungheri D, Jabes E, Morvillo E, Sanfilippo A (1983) J Antibiot 36: 1502–1506
Woodley C, Kilburn JO (1982) Am Rev Respir Dis 126: 586–587
Ungheri D, Della Bruna C, Sanfilippo A (1984) Drugs Exp Clin Res 10: 681–689
Heifets LB, Iseman MD (1985) Am Rev Respir Dis 132: 710–711
Heifets LB, Iseman MD, Lindholm-Levy PJ, Kanes W (1985) Antimicrob Agents Chemother 28: 570–575
Dickinson JM, Mitchison DA (1987) Tubercle 68: 177–182
Hastings RC, Richard VR, Jacobson RR (1984) Lancet 1: 1130
Tomioka H, Saito H, Sato K (1992) Nippon Rai Gakkai Zasshi 61: 157–164
Chiodini RJ (1991) J Antimicrob Chemother 27: 171–176
Perumal VK, Gangadharam PR, Iseman MD (1987) Am Rev Respir Dis 136: 334–337
Treharne JD, Yearsley PJ, Ballard RC (1989) Antimicrob Agents Chemother 33: 1393–1394
Fanfani A, Riva F, Sanfilippo A, Sardi A (1985) Rifabutin LM427 ansamycin, Farmitalia Carlo Erba, Mailand
Sanfilippo A, Della Bruna C, Marsili L, Morvillo E, Pasqualucci CR, Schioppacassi G, Ungheri D (1980) J Antibiot (Tokyo) 33: 1193–1198
Dhillon J, Mitchison DA (1992) Am Rev Respir Dis 145: 212–214
Anand R, Moore J, Feorino P, Curran J, Srinivasan A (1986) Lancet 1: 97–98
Weiser B, Burger H, Eilbott DJ, Gehan K, Flaherty K, GullaJ, Neff S, Davidson B, Anand R, Siegal FP (1989) AIDS 3: 823–827
Perucca E, Grimaldi R, Frigo GM, Sardi A, Monig H, Ohnhaus EE (1988) Eur J Clin Pharmacol 34: 595–599
Skinner MH, Hsieh M, Torseth J, Pauloin D, Bhatia G, Harkonen S, Merigan TC, Blaschke TF (1989) Anti-microb Agents Chemother 33: 1237–1241
Battaglia R, Pianezzola E, Salgarollo G, Zini G, Strolin Benedetti M (1990) J Antimicrob Chemother 26: 813–822
Narang PK, Lewis RC, Bianchine JR (1992) Clin Pharmacol Ther 52: 335–341
Chan SL, Yew WW, Ma WK, Girling DJ, Aber VR, Felmingham D, Allen BW, Mitchison DA (1992) Tuber Lung Dis 73: 33–38
Strolin Benedetti M, Efthymiopoulos C, Sassella D, Moro E, Repetto M (1990) Xenobiotica 20: 1113–1119
Duchene P (1990) Pharmacokinetics of rifabutin (LM 427) in healthy volunteers aged between 30 and 60 years, FCE Report, Farmitalia Carlo Erba, Mailand, Clinical Reference: 18
O’Brian RJ, Lyle MA, Snider DE jr (1987) Rev Infect Dis 9: 519–530
Cocchiara G, Strolin Benedetti MS, Vicario GP, Ballabio M, Giola B, Vioglio S, Vigevani A (1989) Xenobiotica 19: 769–780
Breda M, Pianezzola E, Strolin Benedetti M, Efthy¬miopoulos C, Carpentieri M, Sassella D, Rimodini R (1992) Drug Metab Drug Interact 10: 323–340
Jacobson MA, Yajko D, Northfelt D, Charlebois E, Brosgart C, Sanders CA, Hadley WK (1993) J Infect Dis 168: 112–119
O’Brian RJ, Geiter LJ, Lyle MA (1990) Am Rev Respir Dis 141: 821–826
Pretet S, Lebeaut A, Parrot R, Truffot C, Grosset J, Dinh Xuan AT (1992) Eur Respir J 5: 680–684
Riva M, Crippa S, Di Palma F, Gerini AM, Soresi E, Scoccia S (1990) Ital J Neurol Sci 11: 163–169
Siegal FP, Eilbott D, Burrger H, Gehan K, Davidson B, Kaell AT, Weiser B (1990) AIDS 4: 433–441
Morris JT, Kelly JW (1993) Ann Int Med 119: 171–172
Battaglia R, Salgarollo G, Zini G, Montesanti L, Strolin Benedetti M (1991) Antimicrob Agents Chemother 35: 1391–1396
Maggi N, Pasqualucci CR, Ballota R, Sensi P (1966) Chemotherapia 11: 285–292
Maggi N, Gallo GG, Sensi P (1967) Farmaco, Ed Sci 22: 316–325
US Pat 3342810 (1967), Neth Pat Appl 6509961 (1967) beide an Lepetit, zit. nach C A (1966) 65: 5462d
Moffat AC (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London, S. 960
Lecaillon JB, Febvre N, Metayer JP, Souppart C (1978) J Chromatogr 145: 319–324
Guillaumont M, Leclercq M, Frobert Y, Guise B (1982) J Chromatogr 232: 369–376
Hag
Walther H, Meyer FP (1987) Klinische Pharmakologie antibakterieller Arzneimittel, Urban & Schwarzenberg, München Wien Baltimore, S. 403–410
Simon C, Stille W (1993) Antibiotikatherapie in Klinik und Praxis, Schattauer, Stuttgart New York, S. 262–266
Ludes H (1989) Internist 30: 38–45
Subak-Sharpe JH, Timbury MC, Williams JF (1969) Nature 222: 341–345
Heller E, Argaman M, Levy H, Goldblum N (1969) Nature 222: 273
Acocella G, Brumfitt W, Hamilton-Miller JMT (1980) Thorax 35: 788–791
Riess W (1968) The optimum dosage schedule for Rimactane. Symposium on Rimactane, Basel, S. 36–42
Snider DE, Powell KE (1984) Arch Int Med 144: 589–590
Loos U, Musch E, Jensen JC, Mikus G, Schwabe HK, Eichelbaum M (1985) Klin Wochenschr 63: 1205–1211
Acocella G (1978) Clin Pharmacokin 3: 108–127
Girling DJ, Hitze KL (1979) Bull WHO 57: 45–49
Baciewicz AM, Self TH (1984) Arch Int Med 144: 1667–1671
Acocella G, Conti R (1980) Tubercele 61: 171–177
Eichelbaum M, Mineshita S, Ohnhaus EE, Zekorn C (1986) Br J Clin Pharmacol 22: 49–53
Shaffer JL, Houston JB (1985) Br J Clin Pharmacol 19: 526–528
Zhou HH, Anthony LB, Wood AJJ, Wilkinson GR (1990) Br J Clin Pharmacol 30: 471–475
Bennett PN, John VA, Whitmarsh VB (1982) Br J Clin Pharmacol 13: 387–391
Hoensch HP, Bazer K, Dylewicz P, Kirch W, Goebell H, Ohnhaus EE (1985) Eur J Clin Pharmacol 28: 475–477
Kay L, Kampmann JP, Svendsen TL, Vergman B, Hansen JEM, Skovsted L, Kristensen M (1985) Br J Clin Pharmacol 20: 323–326
Mauro VF, Somani P, Temesy-Armos PN (1987) Eur J Clin Pharmacol 31: 737–738
Mooy J, Baak M v, Kemenade J v, von der Vet A, Rahn KH (1987) Eur J Clin Pharmacol 32: 107–109
Pentikäinen PJ, Koivula IH, Hiltunen HA (1982) Eur J Clin Pharmacol 23: 261–266
Teunissen MWE, Bakker W, Meerburg-van der Torren JE, Breimer DD (1984) Br J Clin Pharmacol 18: 701–706
Castel JM, Cappiello E, LeopaldiD, Latini R (1990) Br J Clin Pharmacol 30: 155–156
Brockmeyer N, Dylewicz P, Habicht H, Ohnhaus EE (1985) Br J Clin Pharmacol 19: 544–548
Neuman M (1979) Antibiotika-Kompendium, H.Huber, Bern Stuttgart Wien, S. 283–289
Otten H, Plempel M, Siegenthaler W (1975) Antibiotika-Fibel, G.Thieme, Stuttgart, S. 548–551
Bergamini W, Fowst G (1965) Arzneim Forsch 15: 953–1002
Scott CK, Castrovilly L, Sundell E, Katz LB, Genna T, Shriver DA, Rosenthale ME, McGuire JL (1986) Dig Dis Sci (Suppl. 31 ): 354S
Shriver DA, Katz LB, Rosenthale ME (1989) Scand J Gastroenterol 24 (Suppl. 164) 10–20
Petersen KU, Winterhager JM (1989) Scand J Gastroenterol 24 (Suppl. 164): 26–34
Beinborn M, Nüstedt V, Sewing KF (1989) Scand J Gastroenterol 24 (Suppl. 164) 21–25
Peterson-von Gehr JKH, Siefert.HM, SteinkeW (1989) Scand J Gastroenterol 24 (Suppl. 164): 46–51
Ahr HJ, Karl W, Scherling D, Wünsche C (1989) Scand J Gastroenterol 24 (Suppl. 164): 52–57
Dammann HG, Dreyer M, Müller P, Simon B (1989) Scand J Gastroenterol 24 (Suppl. 164): 207–2131.
Vlahov V, Kirkov V, Popov P, Gerova Z (1989) Scand J Gastroenterol 24 (Suppl. 164): 169–173
Hartnagel RE, Porter MC, Clemens GR, Abrutyn D, Kille JW, Kowalski RL, Norberg KC, Schlueter G, HerboldB (1989) Scand J Gastroenterol 24 (Suppl. 164): 42–45
Franceschi G et al, Foglio M, Alpegiani M, Battestini C, Bedeschi A, Perrone E, Zarini F, Arcamone F (1983) J Antibiotics 36: 938–941
Cassinelli G et al, Cassinelli G, Corigli R, Orezzi P, Ventrella G, Bedeschi A, Perrone E, Borghi D, Franceschi G (1988) J Antibiotics 41: 984–987
Neu HC, Chin NX, Labthavikul P (1985) J Antimicrob Chemother 16: 305–313
Van der Auwera P, Ernst F, Grenier P, Glupczynski Y, Husson M, Klastersky J (1987) J Antimicrob Chemother 20: 179–189
Riva F (1985) Drugs Fut 10: 119–120
Barry AL, Jones RN (1988) Eur J Clin Microbiol Infect Dis 7: 807–809
Said AA, Livermore DM (1989) J Antimicrob Chemother 23 (SupplC): 103–108
Chin NX, Neu HC (1989) J Antimicrob Chemother 23 (Suppl C): 95–101
Dornbusch K, Henning C, Linden E (1989) J Antimicrob Chemother 23 (Suppl C): 109–117
Webberley JM, Wise R, Andrews JM, Ashby JP, Wallbridge D (1988) J Antimicrob Chemother 21: 445–450
Efthymiopoulos C, Battaglia R, Strolin Benedetti M (1991) J Antimicrob Chemother 27: 517–526
Lovering AM, White LO, Lewis DA, Mac Gowan AP, Routh KR, Pickin DM, Reeves DS (1989) J Antimicrob Chemother 23 (SupplC): 179–195
Sassella D, Cassinelli G, Corigli R, Dewland P, Hutt V, Lode H, Ballard RC (1989) J Antimicrob Chemother 23 (Suppl C): 197–203
Strolin Benedetti M, Battaglia R, Vicario G, Roncucci R (1989) J Antimicrob Chemother 23 (SupplC): 173–177
Jannuzzo MG, Mandelli M, Strolin Benedetti M, Moro E, Carnovali M, Vaiani R, Sassella D (1989) Eur J Clin Pharmacol 36: 633–635
Norrby SR, Burman LA, Sassella D, Corigli R, Cassinelli G, Franceschi G, Dornbusch K (1990) J Antimicrob Chemother 25: 371–383
Saathoff A, Lode H, Hampel B, Deppermann KM, Borner K, Koeppe P (1990) Antimicrob Agents Chemother 34: 1001–1006
Lovering AM, Gowan AP, Lewis DH, Reeves DS (1992) J Antimicrob Chemother 29: 179–185
Efthymiopoulos C, Strolin Benedetti M, Sassella D, Boobis A, Davies D (1992) Antimicrob Agents Chemother 36: 1958–1963
Cassinelli G, Corigli R, Orezzi P, Ventrella G, Badeschi A, Perrone E, Borghi D, Franceschi G (1988) J Antibiot 41: 984–987
Schliamser SE, Broholm KA, Liljedahl AL, Norrby SR (1988) J Antimicrob Chemother 22: 687–695
Schliamser SE, Cars O, Norrby SR (1991) J Antimicrob Chemother 27: 405–425
Brughera M, Scampini G, Ferrari ML, Nava A, Mazue G (1989) J Antimicrob Chemother 23 (Suppl C): 129–135
NN (1993) Drugs Fut 18: 373
NN (1991) Drugs Fut 16: 313–316
Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia, 2. Aufl., Noyes Publications, Park Ridge, New Jersey, USA
Belg Pat 660, 244 (1965), zit. nach CA (1965) 63:17965h
Eur Pat Appl EP 492,719 (1990), zit. nach CA (1992) 117:170960q
van Dijk I, Moed HD (1973) Recl Trav Chim Pays Bas 92: 1281
Musumarra G, Scarlata G, Cirma G; Romano G, Palazzo S, Clementi S, Giulietti G (1985) J Chromatogr 350: 151
Halmekoski J, Mankoen L (1973) Farm Aikak 82:111, zit. nach CA (1974) 80: 95409d
Gross A, Brown K, Baird-LambertJA, Nation RL (1987) J Chromatogr 416: 400
Lin LS, Caritis SN, Wong LK (1984) J Pharm Sci 73: 131
Travis BE, McCullough JM (1993) Pharmacotherapy 13: 28–26
Kawarabayashi T, Tsukamoto T, Kishikawa T, Sugimor H (1989) Gynecol Obstet Inivest 28: 132–137
Levin LC, Korenman SG, Krall JF (1980) Biol Reprod 22: 493–499
Berg G, Andersson RGG, Rydén G (1985) Am J Obstet Gynecol 151: 392–396
Kroeger EA, Marshall JM (1974) Am J Physiol 226: 1298–1303
Kawarabayashi T, Tsukamoto T, Hamasaki Y, Kaneko Y, Ikeda M, Sugimori H (1991) Gynecol Obstet Invest 31: 130–135
Gandar R, de Zoeten LW, Schoot JB (1980) Eur J CUn Pharmacol 17: 117–122
Gross AS, Brown KF (1985) Eur J 44: 259–264
Kuhnert BR, Gross TL, Kuhnert PM, Erhard P, Brashar WT (1986) Clin Pharmacol Ther 40: 656–664
Pacifici GM, Kubrich M, Giuliani L, de Vries M, Rane A (1993) Eur J Clin Pharmacol 44: 259–264
Caritis SN, Lin LS, Venkataramanan R, Wong LK (1988) Am J Obstet Gynecol 159: 328–332
Pre-par, Fachinformation der Fa. duphar, Februar 1992
Morgan DJ, Lamont RF (1992) Curr Obstet Gynecol 2: 229–234
Higby K, Xenakis MJ, Pauerstein CJ (1993) Am J Obstet Gynecol 168: 1247–1259
Kuhnert-Brandstatter M, Geiler M, Wurian I (1983) Sci Pharm 51: 34
Armson BA, Samuels P, Miller F, Verbalis J, Main EK (1992) Am J Obstet Gynecol 167: 758–765
Kuhnert-Brandstätter M, Geiler M, Wurian I (1983) Sci Pharm 51: 34
Sill AD, Housmyer CL, Gibboney K (1987) Tetrahedron 43: 1177
Yamaji A, Hashizume T, Masuike Y (1987) Byoin Yakugaki 13:298, zit. nach CA (1988) 108: 156339b
Gottstein WJ, Minor WF, Cheney LC (1959) J Am Chem Soc 81: 1198–1201
Siedel W, Soder A, Lindner F (1958) Muench Med Wochenschr 100: 1–4
Roth HJ, Brandes R (1965) Arch Pharm 298: 34–42
Mazzola EP, Melin JA, Wayland LG (1980) J Pharm Sci 69: 229–230
Walther H, Meyer FP (1987) Klinische Pharmakologie antibakterieller Arzneimittel, Urban und Schwarzenberg, Munchen Wien Baltimore, S. 245–262
Simon C, Stille W (1989) Antibiotika-Therapie in Klinik und Praxis, Schattauer, Stuttgart New York, S. 133–142
Reese RE, Betts RF (Hrsg.) (1991) A practice approach to infectious diseases, Little, Brown & Co, Boston Toronto London, S. 968–974
Zimmermanns MM, Wiedemann B (1989) Index Infektionen-Erreger-Antibiotika, Zett-Verlag, Steinen
Neth pats 6609552; zit. nach C A 67:54123u
Perez-Reyes E, Kalyanaraman B, Mason RP (1980) Mol Pharmacol 17: 239–244
Knox RJ, Knight RC, Edward DL (1981) Br J Cancer 44: 741–745
Rowley DA, Knight RC, Skolimowskil M, Edward DI (1979) Biochem Pharmacol 28: 3009–3013
Wolf FJ, Alvaro R, Chapin LR, Green ML, Wolf DE, Koniuszy FR, Steffens JJ, Jacob AA (1984) J Agric Food Chem 32: 706–711
Wolf FJ, Baylis FP, Smith GE, Rosenblum C, Meriwether HT, Alvaro RF, Wolf DE, Koniuszy FR, Jacob AА (1983) J Agric Food Chem 31: 559–564
Smith GE, Wolf FJ, Baer JE (1975) Ronidazole: Metabolism in swine; unpublished report
Olson LD, Rodabaugh DE (1977) Am J Vet Res 38: 1461–1469
Olson LD, Rodabaugh DE (1976) Am J Vet Res 37: 763–767
Szent-Ivanyi T, Molnar L (1980) Bull Off Int Epiz 92: 895–907
Taylor DJ (1976) Vet Rec 99: 453–456
Taylor DJ (1974) Vet Rec 7: 215–216
Sullivan TW, Grace OD, Aksoy A (1977) Poultr Sci 56: 571–576
Peterson EH (1967) Poultr Sci 47: 1245–1250
Mar 29, S.965
Kracmar J, Kracmarova J, Kovarova A, StejskalZ, Helingerova H (1988) Pharmazie 43: 173–176
Mitteilung der Firma Sanofi Winthrop GmbH, München
Kullberg MP, Koss R, O’Neil S, Edelson J (1979) J Chromatogr 173: 153–163
Holzgrabe U, Branch S (1994) Magn Res Chem in press
Dobson RA, O’Connor RI, Poulin SA, Kundsin RB, Smith TF, Came PE (1980) Antimicrob Agents Chemother 18: 738–740
Milatovic D, Machka K, Galla O, Braveny I (1978) Infection 6: 242–243
Braveny I, Machka K (1980) Arzneim Forsch 30: 1476–1478
Jurek EA, Weiner LB, Granato PA (1983) Chemotherapy (Basel) 29: 262–264
Park GB, Saneski I, Weng T, Edelson I (1982) J Pharm Sci 71: 461–462
Daten der Firma Sanofi Winthrop GmbH (siehe auch Fachinformation zu Winuron®; Stand: August 1987)
Maigaard S, Frimodt-Moller N, Madsen PO (1980) Urol Res 8: 113–116
Maigaard S, Frimodt-Moller N, Hoyme U, Madsen PO (1979) Invest Urol 17: 149–152
Calubiran OV, Crisologo Vizconde LB, Tupasi TE, Torres CA, Limson BM (1982) Brit J Vener Dis 58: 231–235
Harrison WO, Wignall FS, Kerbs SBJ, Berg SW (1984) Lancet 1984/I:566
Limson BM, Macasaet RK, Salem JJ, Beling CG, Burnham HA (1979) Curr Ther Res 26: 842–847
Elks J, Ganellin CR (Hrsg.) (1990) Dictionary of Drugs, Chapman and Hall, London New York Tokyo
Sewing KF, Beil W, Hanneman H (1988) Drugs 35 (Suppl. 3): 25–29
Tarutani M, Sakuma H, Shiratsuchi K, Mieda M (1985) Arzneim Forsch 35: 703–706
Scholtholt J, Bickel M, Herling AW (1988) Drugs 35 (Suppl. 3): 35–40
Tryba M, Kurz-Muller K (1988) Scand J Gastroenterol 23 (Suppl. 146): 153–158
Collins JD, Pidgen AW (1988) Drugs 35 (Suppl. 3): 41–47
Huttemann W (1988) Drugs 35 (Suppl. 3): 90–95
Hetschel E, Schiitze K and members of the International Cooperative Roxatidine Study Group (1988) Drugs 35 (Suppl. 3): 96–101
Judmaier G (1988) Drugs 35 (Suppl. 3): 120–126
Rösch W (1988) Drugs 35 (Suppl. 3): 127–133
Brunner G (1988) Drugs 35 (Suppl. 3): 102–105
Borsch G (1988) Drugs 35 (Suppl. 3): 134–138
Damman HG, de Looze SM, Bender W, Labs R (1988) Scand J Gastroenterol 23 (Suppl. 146): 121–134
Collins J (1988) Scand J Gastroenterol (Suppl. 146 ): 89–99
Shibata K, Itaya T, Yamakoshi N, Kurata S, Koizumi N, Tarutani M, Sakuma H, Konishi K (1979) EP 24510, JP 81115750, USP 4293557, zit. nach CA (1981) 95: 80465e
Privatmitteilung: Albert-Roussel Pharma GmbH, 6200 Wiesbaden
1985) Drugs of the Future 10:995
Herstellerangaben aus Standardinformation fur Krankenhausapotheker
Young RA, Gonzales JP, Sorkin EM (1989) Drugs 37: 8–43
Bauernfeind A, Schweighart S, Jungwirth R, Zeininger C (1990) Fortschr antimicrob antineoplast Chemother 9: 47–53
Wise R, Kirkpatrick B, Ashby J, Andrews JM (1987) Antimicrob Agents Chemother 31: 1051–1053
Puri SK, Lassman HB (1987) J Antimicrob Chemother 20 (Suppl B): 89–100
Periti P, Mazzei T (1987) J Antimicrob Chemother 20 (Suppl B): 107–112
Nilsen OG (1987) J Antimicrob Chemother 20 (Suppl B): 81–88
Bergogne-Berezin E (1987) J Antimicrob Chemother 20 (Suppl B): 113–120
Begue P, Kafetzis DA, Albin H, Safran Ch (1987) J Antimicrob Chemother 20 (Suppl B): 101–106
Lassman HB, Puri SK, Ho I, Sabo R, Mezzino MJ (1988) J Clin Pharmacol 28: 141–152
Bryskier A, Chantot JF, Gasc JC, Chretien P (1990) Fortschr antimicrob antineoplast Chemother 9: 1–17
Boeckh M, Daeschlein S, Borner K, Koeppe P, Lode H (1990) Fortschr antimicrob antineoplast Chemother 9: 75–83
Simon C (1990) Fortschr antimikrob antineoplast Chemother 9: 113–118
Krausse R, Ullmann U (1990) Fortschr antimikrob antineoplast Chemother 9: 55–64
Ruckdeschel G, Klammert R, Ehret W (1990) Fortschr antimikrob antineoplast Chemother 9: 65–74
Hoppe JE (1990) Fortschr antimikrob antineoplast Chemother 9: 89–94
Hoffken G, Lode H, Rahlwes M, Wagner J (1990) Fortschr antimikrob antineoplast Chemother 9: 95–100
Chang HR, Pechère JC (1990) Fortschr antimikrob antineoplast Chemother 9: 101–106
Saint-Salvi B, Tremblay D, Surjus A, Lefebvre MA (1987) J Antimicrob Chemother 20 (Suppl B): 121–129
Panova D, Nikolov St (1971) Farmatsiya 21: 43
Sannié C, Lapin H (1957) Bull Soc Chim Fr 301: 1237
Sannié C, Lapin H (1955) C R Acad Sci 241:1498
Iskenderov G (1970) Khim Prir Soedin 6: 488
Iskenderov G (1968) Farmatsiya 17: 37
Iskerendov G (1967) Khim Prir Soedin 3: 216
Krokhmalyuk W (1975) Issled Obi Farm Khim 151:6; zit. nach CA 86: 96051s
Tada A, Shoji J (1972) Chem Pharm Bull 20 (8): 1729–1734
Nikolov St, Joneidi M, Panova D (1976) Pharmazie 31 (9): 611–612
Burn D, Ellis B, Petrow V (1958) J Chem Soc 1958: 795–799
Verne JM, de Montrichard C, Chevillard L, Ranson M (1960) Ann Chirurg 14: 2121–2151
Marcelon G, Vanhoutte PM (1988) Phlebology 3 (Suppl l): 51–54
Rubanyi G, Marcelon G, Vanhoutte PM (1984) Gen Pharmacol 15: 431–434
Felix W, Nieberle J, Schmidt G (1983) Phlebol Proktol 12: 209–218
Rudofsky G, Hajek M (1983) Med Klin Prax 78: 48–52
Nakanishi H, Kaneda N (1987) Yakugaku Zasshi 107: 780–784
Felix W (1986) Therapiewoche 36: 1083–1089
Seidenberger AV, Müller I, Heindl HJH (1974) Therapiewoche 24: 866–881
Berg D (1990) Fortschr Med 108: 473–476
Hörhammer L, Wagner H, Arndt HG, Hitzler G, Farkas L (1968) Chem Ber 101: 1183–1185
Dibbern HW (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf
Eigene Messungen
Kuschinsky G, Dupont W, Henners R (1949) Naunyn-Schmiedeberg’s Arch Exp Pathol Pharmakol 207: 138–142
Voelkel A (1953) Aerztl Forsch 7: 228–234
Richards RK, Kueter KE (1948) J Pharmacol Exp Ther 94: 372–381
Ferriola PC, Cody V, Middleton E Jr (1989) Biochem Pharmacol 38: 1617–1642
Моro A, Paya M, Rios JL, Alcaraz MJ (1990) Biochem Pharmacol 40: 793–797
Robak J, Gryglewski RJ (1988) Biochem Pharmacol 37: 837–841
Pincemail J, Deby C, Thirion A, de Bruyndister M, Couttier R (1988) Experientia 44: 450–453
Moore PK, Griffiths RJ, Lofts FJ (1983) Biochem Pharmacol 32: 2813–2817
Gryglewski RJ, Korbut R, Robak J, Swies J (1987) Biochem Pharmacol 36: 317–322
Odetti PR, Borgoglio A, de Pascale A, Rolandi R, Adezati L (1990) Diabetes 39: 796–801
Zyma VL, Miroshnichenko NS, Danilova VM, En Gin E (1988) Gen Physiol Biophys 7: 165–175
Medina JH, Paladina AC, Wolfman C, Levi de Stein M Calvo D, Diaz LE, Pena C (1990) Biochem Pharmacol 40: 2227–2231
Ryski M, Duriasz-Rowinska H, Rewerski W (1979) Acta Physiol Pol 30: 385–391
Francis AR, Shetty TK, Bhattacharaya RK (1989) Carcinogenesis 10: 1953–1955
Sawai Y, Koshaka K, Nishiyama Y, Ando K (1987) Arzneim Forsch 37: 729–732
Bokkenheuser VD, Shakleton CHL, Winter J (1987) Biochem J 248: 953–956
Alldrick AJ, Lake BG, Mallett AK, Rowland IR (1988) Progr Clin Biol Res 280: 139–142
Bollinger AA (1972) Angiologia 9: 397–400
Pfeifer K, Mehnert WH, Hulsmann W (1970) Dtsch Gesundheitswes 25: 386–391
Stühlinger W, Berek K, Grosswang F, Schauer N (1990) Schweiz Med Wochenschr 120: 345–348
Böhm K (1959) Arzneim Forsch 9: 647–653
Rueff J, Laires A, Gaspar J, Rodrigues A (1990) Mutagenesis 5: 393–396
Negwer M (1987) Organic-chemical drugs and their synonyms, 6. Aufl., Akademie Verlag, Berlin
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Albinus, M. et al. (1994). R. In: Albinus, M., et al. Hagers Handbuch der Pharmazeutischen Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57880-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-57880-9_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63389-8
Online ISBN: 978-3-642-57880-9
eBook Packages: Springer Book Archive